Cargando…
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
Parkinson’s disease (PD) is the second most common neurodegenerative disease and a prime target of cell therapies. In fact, aborted fetal tissue has been used as donor material for such therapies since the 1980s. These cell therapies, however, suffer from several problems, such as a short supply of...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969678/ https://www.ncbi.nlm.nih.gov/pubmed/36843101 http://dx.doi.org/10.1186/s41232-023-00269-3 |